Karolinska Development (investor - Corporate Investor)
Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. The business model is to: SELECT the most commercially attractive medical innovations; DEVELOP innovations to the stage where the greatest return on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products.
Showing 3 of 8 tracked Nordic investments in:
|Name||Date||Round value||Total raised|
|Modus Therapeutics||Feb 2017||3.59M||3.59M|
* The round values and totals raised are in USD.
** Click on the company for its details and on the round amount for the investment details.